The prevalence of diabetic peripheral neuropathy and related factors

Iranian Journal of Public Health

Volumn 40, Issue 3, 2011, Pages 55-62

  Tabatabaei Malazy, O ^a   Mohajeri Tehrani, M R ^a   Madani, S P ^a,b   Heshmat, R ^a   Larijani, B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic neuropathy; Monofilament; Prevalence; Risk factors of neuropathy

Indexed keywords

EID: 84858327372     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Khatib O, Tabatabaei Malazy O (2007). Prevention and public approach to diabetic foot. Iranian J of Diabetes & Lipid Disorders, 7(2): 123-33.
2. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. (2008). Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care, 31(1): 96-8.
3. Singh D (2006). Diabetic foot: It is time to share the burden. Calicut Med J, 4(3): e 4.
4. Abolhasani F, Mohajeri Tehrani MR, Tabatabaei Malazy O, Larijani B (2003). Burden of diabetes and its complications in Iran in Year 2000. Iranian J of Diabetes & Lipid Disorders, 5(1): 35-48.
5. Songer TJ, Zimmet P (1995). Epidemiology of type 2 diabetes: an international prospective. Pharmacoeconomics, 1: 1-11.
6. Wild SH, Roglic G, Sicree R, Green A, King H. (2002). Global burden Diabetes Mellitus in the year 2000. Available from: www.who.int.
7. Calle-Pascual AL, Redondo MJ, Ballesteros M, Martinez Salinas MA, Diaz JA, De Matias P, et al. (1997). Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. Diabetes Metab, 23: 519-23.
8. Murray HJ, Young MJ, Mollis S, Boulton AJ (1996). The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med, 13: 979-83.
9. Pecoraro RE, Reiber GE, Burgess EM (1990). Causal pathway to amputations: basis for prevention. Diabetes Care, 13: 513-21.
10. Reiber GE, Pecoraro RE, Koepsell TD (1992). Risk factors for amputation in patients with diabetes mellitus a: case-control study. Ann Intern Med, 117:97-105.
11. McNeely MJ, Boyko EJ, Ahroni JH, Sensel VL, Reiber GE, Smith DG, et al. (1995). The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care, 18(2): 216-19.
12. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Green DA (1994). A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care, 17: 1281-89.
13. Young MJ, Boulton AJ, Macleod AF, Williams DR, Sonksen PH (1993). A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinical population. Diabetologia, 36:150.
14. Rahman M, Griffin SJ, Rathmann W, Wareham NJ (2003). How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med, 20(5): 368-74.
15. st ed. Vista, Iran, p. 5 Available from: http://emri.tums.ac.ir/dmfoot-en.
16. Lunetta M, Le Moli R, Grasso G, Sangiorgio L (1998). A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract, 39:165-72.
17. Armstrong DG (2000): The 10-g monofilament: the diagnostic diving rod for the diabetic foot? [Editorial]. Diabetes Care, 23:887.
18. Pirart J (1978). Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care, 1:168-88.
19. Dyck PJ, Katz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. (1993). The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology, 43: 817-24.
20. Little AA, Edwards JL, Feldman EL (2007). Diabetic neuropathies. Pract Neurol, 7: 82-92.
21. Franse LV, Valk GD, Dekker JH, Heine RJ, van Eijk JTM (2000). Numbness of the feet is a poor indicator for polyneuropathy in type 2 diabetic patients. Diabetic Med, 17:105-10.
22. American Diabetes Association (2011). Standards of medical care in diabetes-2011. Diabetes Care, 34 (Suppl 1):S11-S61.
23. Young MJ, Breddy JL, Veres A, Bulton AJ (1994). The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care, 17: 557-60.
24. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ (1991). Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract, 13:63-67.
25. Olmos PR, Cataland S, O'Dorisio TM, Casey CA, Smead WL, Simon SR (1995). The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci, 309: 76-82.
26. Brike J, Cornwall MA, Jackson M (1988). Relationship between hallux limitus and ulceration of the great toe. Sports Phys Ther Orthop, 10: 172-76.
27. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG (1998). Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med, 158: 157-62.
28. Bouya F, Bandarian F, Larijani B, Pajouhi M, Noraei M, Lotfi J (2005). Potential risk factors for diabetic neuropathy: a case-control study. BMC Neurol (open access):5, 24.
29. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. (1996). And the EURODIAB IDDM Study Group. Prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia, 39: 1377-84.
30. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, et al. (1989). Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes, 38(11): 1456-61.
31. Boyko EJ, Ahroni JH, Stensel B, Forsberg RC, Davignon DR, Smith DG (1999). A prospective study of risk factors for diabetic foot ulcer. The Seatlle Diabetic Foot Study. Diabetes Care, 22:1036-42.
32. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A (2000). Screening tech-niques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care, 23:606-11.
33. The DCCT Research Group (1998). Factors in the development of diabetic neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes, 37: 476-81.
34. Al-Mahroos F, Al-Roomi K (2007). Diabetic neuropathy, Foot ulceration, Peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinicbased study. Ann Saudi Med, 27(1): 25-31.
35. Boru Ut, Alp R, Sargn H, Kocer A, Sargn, Luleci A, et al (2006). Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Available from: www.cababstractsplus.org
36. Ugoya SO, Ugoya TA, Puepet FH, Agaba EI, Ogunniyi AO (2008). Risk determinants of diabetic peripheral neuropathy in Jos, North. Central Nigeria. J of Chinese Clinical Medicine, 3(5):285-91.